What's breaking now, across thousands of outlets.
The companies said the findings suggest the treatment has a “limited” impact in HER2-low breast cancer, an area where AstraZeneca and Daiichi Sankyo’s Enhertu has already set a high bar.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
New research challenges a leading explanation for the decline in overdose deaths in the United States.
New research shows that using hormone therapy with a GLP-1 during menopause may lead to greater weight loss. Tatsiana Volkava · Moment/Getty A study presented at the 2026 Annual Meeting of The…
The final rule retains most of the core objectives from the December 2025 proposal, but ONC significantly scaled back its approach, stopping short of the sweeping overhaul of the health IT…
Roche will seek European approval for its promising new breast cancer pill giredestrant later than it once expected, highlighting how US drug pricing pressure may be affecting pharmaceutical…
The campaign seeks to raise awareness and improve vaccine uptake through engagements in schools, churches, mosques and other public places across the region.
The Ghana Physician Assistants Association (GPAA) has begun a free community health screening exercise at four locations in Techiman as part of its 23rd Annual General Conference.
